Christopher Porter is named as a lobbyist on federal disclosure filings for 1 client through Travere Therapeutics. The most recent filing naming them posted in October 2026. Issues reported include Copyright/Patent/Trademark, Health Issues, Pharmacy and Medical/Disease Research/Clinical Labs.
Pay is not disclosed for individual lobbyists. Filings do not confirm that records with the same name are one person, so this page may combine people who share the name Christopher Porter. See the Capitol Clarity rankings and method.